Kafrit 2025: Volumes Are Still There, but the Test Has Shifted to Margins and Finke Integration

Getting to Know the Company

Kafrit is not just another Israeli plastics plant. It is a global group of masterbatches and compounds for the plastics industry, with operations in Israel, Germany, Sweden, China, Canada and the United States, 952 employees, and estimated production capacity of 173.4 thousand tons per year. It sells to industrial customers on a short-order model, without a long backlog, and with an average delivery time of 14 days. That matters, because this is not a business with the visibility of an infrastructure contractor or a software company with annual contracts. When demand weakens or spreads compress, the effect shows up quickly.

A superficial read of 2025 can miss the core point. At first glance, you see revenue down 5%, gross profit down 10%, and operating profit down 23%, and conclude that it was simply a weak year. That is only half the story. Annual volumes were down just 1%, and fourth-quarter volumes actually rose 1.2%. The real problem in 2025 was not disappearing customers. It was a combination of weaker end-market demand in sensitive categories, price and FX pressure, weak utilization in North America, and a new acquisition that added revenue but not profit.

What is still working? The portfolio remains diversified, Asia stayed positive in both volume and earnings, Europe still generated the bulk of segment profit, and operating cash flow actually rose to NIS 126.8 million. What is still messy? The fourth quarter was very weak, North America was barely profitable, the first quarter of Finke under Kafrit ownership contributed a net loss of about NIS 3.9 million, and cash at the parent-company level ended the year at only NIS 224 thousand. At the same time, Kafrit still carries meaningful floating-rate debt, continues to distribute cash, and trades with weak daily liquidity, which limits how easily the market can underwrite a story that still needs proof.

In other words, 2026 currently looks like a proof year. For the reading to improve, Kafrit needs to show that the weakness at the end of 2025 was a cyclical trough rather than a structural shift, that Finke becomes a profit contributor rather than a drag, and that North America can return to a reasonable level of profitability relative to its revenue base. If that does not happen, the market will keep looking at a company that continues to acquire, continues to distribute, and still has not proven that its strategic moves translate into cleaner earnings.

The table below shows why Kafrit should be read through segment profitability and utilization rather than headline revenue alone:

Events and Triggers

The Finke acquisition

The first trigger: the acquisition of Karl Finke in Germany. The deal closed on October 1, 2025, purchase consideration amounted to about NIS 61.5 million, and the group also acquired the real estate used by the business for EUR 9 million. Strategically, the move makes sense. Finke operates in color masterbatches for plastics processing, with specialization in cosmetics and personal care, which fits the direction management has been signaling for some time: strengthen color exposure and expand the portfolio toward higher-value products.

But the other side of the move showed up in the numbers immediately. From the acquisition date through year-end, Finke contributed about NIS 23.7 million in consolidated revenue, but also a net loss of about NIS 3.9 million. Management explains that the fourth-quarter operating loss was also affected by customer uncertainty around Finke in the period before the acquisition. That wording matters. Kafrit did not buy a clean asset that slid neatly into the group. It bought a business out of a voluntary insolvency process, after a reduction of around 20 employees and while commercial activity still needed stabilization.

That means Finke is both an opportunity and a burden in the near term. It can improve the product mix, but at this stage it also raises execution complexity, weighs on margins, and increases the proof burden for 2026.

A very weak year-end

The second trigger: the fourth quarter. This is where the weakness turned from an annual trend into a concrete operational problem. Revenue fell to NIS 301.5 million from NIS 315.6 million in the comparable quarter. Gross profit fell to NIS 53.9 million, gross margin compressed to 17.9%, and operating profit almost disappeared at just NIS 1.7 million versus NIS 15.5 million a year earlier. Quarterly EBITDA fell from NIS 30.7 million to NIS 19.1 million.

At an operating level, this sharpens the economic structure of the business. When December is weak, when customers shut down plants around year-end, and when there is no long backlog to protect the line, the damage shows up fast. When the company also carries a broad manufacturing footprint with low utilization, margins compress even faster.

After the balance sheet: one bullish signal, one governance noise point

The third trigger: after the balance-sheet date, the controlling shareholder adopted an irrevocable plan to acquire company shares for up to NIS 3 million. This does not inject cash into the company, but it does create a signal that the controlling owner is willing to add exposure in the market.

The fourth trigger: at the same time, Kafrit called a shareholder meeting to approve the grant of 125 thousand options to the chairman and 140 thousand options to the CEO. This does not decide the operating thesis, but it does keep capital allocation and governance under the spotlight precisely at a time when profitability has weakened and parent-level cash is very thin.

Efficiency, Profitability and Competition

This is not mainly a volume problem. It is an earnings-quality problem

This is the key number: sales fell 5% in 2025, but annual physical volume was down only 1%. In the fourth quarter, volume actually rose 1.2% while operating profit fell 89%. That tells you the damage came much more from price, FX, utilization and fixed-cost absorption than from a collapse in throughput.

Management’s description of the business environment is consistent with that reading. In the second half of 2025, the global plastics industry remained weak, with excess capacity, pressure on polymer pricing, weak demand in packaging, agriculture and construction, and additional uncertainty around the U.S. tariff program. Kafrit also states explicitly that roughly one-third of the annual sales decline came from the effect of the shekel exchange rate.

That matters analytically, because at Kafrit a profit squeeze does not show up only in the top line. It shows up through gross margin falling from 22.4% to 21.2%, operating margin falling from 8.8% to 7.1%, and selling expenses remaining high relative to lower sales. In 2025, selling and marketing expenses rose to NIS 109.9 million, and G&A rose to NIS 77.7 million, including a bad-debt provision of roughly NIS 4 million for a bankrupt German customer.

North America remained the revenue engine, but almost stopped being a profit engine

On a segment basis, 2025 reveals a gap that is easy to miss if you only look at the consolidated result. North America generated NIS 450.8 million of external revenue, more than any other segment, but only NIS 1.4 million of segment profit. In the prior year, the same segment generated NIS 17.9 million. The company ties a significant part of the damage to the construction slowdown in the U.S., which also fits the fact that capacity utilization in North America was only 47%.

By contrast, Asia, with NIS 218.4 million of revenue and NIS 22.0 million of segment profit, looks much healthier economically. Europe was down in revenue, but still produced NIS 54.8 million of segment profit, the highest in the group. That means anyone reading Kafrit mainly as a North American revenue story is missing the fact that, in 2025, the real economic burden was carried much more by Europe and Asia.

The portfolio is moving in the right direction, but margins have not followed yet

The product mix gives a useful strategic signal. Injection molding grew from NIS 189.5 million in 2024 to NIS 232.3 million in 2025, rising from 14% to 18% of total revenue. Profile extrusion held at about NIS 77.6 million. Meanwhile, PEX Pipes fell from NIS 128.6 million to NIS 80.9 million, and Sheets and Agri Films were also weaker.

At the narrative level, that looks like a shift toward the areas Kafrit says it wants to emphasize: more colors, more injection, more specialized solutions, and less exposure to some slower-moving categories. But caution is required here. If the portfolio shift were already translating into better economics, it should have shown up in operating performance. Instead, 2025 shows that the strategic direction is there, but the economic delivery is not yet.

The industry structure does not leave much room for mistakes

Kafrit places itself in the mid-sized multinational layer of the industry, below giants like Avient and Ampacet but above small local specialists. That position offers flexibility, technical solutions and geographic reach, but it also carries a clear disadvantage: it does not have the purchasing power and scale advantages of the global leaders, and it does not have the simplicity of a focused niche player. When the industry faces excess supply, price pressure and underutilization, a company in this tier feels the squeeze quickly.

Cash Flow, Debt and Capital Structure

Operating cash flow held up, but this was not a relaxed cash year

At the consolidated level, operating cash flow rose to NIS 126.8 million, versus net income of NIS 46.9 million. That is a positive gap, but it does not mean the business suddenly became structurally more cash generative. Cash flow also benefited from a NIS 14.3 million decline in receivables, a NIS 30.3 million decline in inventory, and NIS 63.3 million of depreciation and amortization. That is supportive, but it is not the same thing as stronger profitability.

This is where the framing matters. On a broad cash-use view, and still before gross bank-debt principal repayments, Kafrit generated NIS 126.8 million from operations, but used NIS 104.4 million in investing activity, including roughly NIS 61.5 million for the Finke acquisition and about NIS 48.2 million of capex and intangible investment, and paid NIS 20 million in dividends during the year. Add NIS 7.3 million of lease principal repayments, and it becomes clear that operating cash did not leave much surplus after the year’s real cash needs.

In practice, consolidated cash rose by only NIS 3.6 million to NIS 35.0 million at year-end. In other words, the business was not in a liquidity crisis, but it was not sitting on excess flexibility either. Kafrit kept investing, acquiring and distributing, and it also leaned on bank funding and the ability to roll facilities.

The really important layer is the parent-company layer

This is where one of the key yellow flags sits. In the separate parent-company numbers, year-end cash stood at only NIS 224 thousand, versus NIS 5.45 million at the end of 2024. At the same time, the parent relied on NIS 112.3 million of loans to subsidiaries, NIS 409.1 million of investments in subsidiaries, and net dividends and loans received from subsidiaries of about NIS 27.0 million during the year. This is not an accounting technicality. It is exactly the distinction between value created somewhere in the group and cash that is actually accessible at the listed-company level.

The implication is that anyone following Kafrit needs to watch not only consolidated EBITDA, but also the subsidiaries’ ability to upstream cash. That matters even more once you add the post-balance-sheet approval of another NIS 5.5 million dividend.

Debt looks manageable on the surface, but not every buffer is wide

Short- and long-term bank debt stood at about NIS 372.2 million at the end of 2025, versus roughly NIS 377.8 million at the end of 2024. About 85% of short-term credit carries floating interest, and the company itself estimates that a 1% increase in rates would add about NIS 3 million to annual finance costs. The company also states that it had around NIS 130 million of unused credit lines.

So far, the picture looks acceptable. But once you move into the covenant details, it gets more nuanced. Net financial debt to EBITDA stood at 2.1 against a ceiling of 6.5, which is comfortable. The current ratio was 1.2 against a minimum of 1.0, also acceptable. But the ratio between EBITDA and total long-term loan principal and interest payments stood at only 1.62 versus a minimum requirement of 1.6. That is compliance, but tight compliance. Put differently, Kafrit is not pressing on every covenant, but it does have at least one metric that sits close enough to the floor to matter.

Forecasts and Outlook

Finding one: Kafrit is not entering 2026 from a position of extreme volume weakness. It is entering from a margin and utilization problem.

Finding two: Finke has already widened the product set and added European revenue, but so far it has added more execution burden than profit.

Finding three: The market should focus much more on North America than on the group as a whole. That is where the largest gap exists between business size and economic contribution.

Finding four: Strong operating cash flow overstates financial comfort because the parent-company cash position is much tighter.

Finding five: Kafrit’s expansion agenda remains relatively aggressive versus its current operating picture. Management is not only talking about integration. It is also talking about further acquisitions, emerging markets, India and Mexico.

2026 is a proof year, not a breakout year

Management states clearly that it is difficult to assess the coming year because of the war with Iran, broader Middle East uncertainty, tariff uncertainty, and instability in raw-material and energy pricing. That is not the language of a company looking at a clean runway. It is the language of a management team preparing for a year that will depend on reacting quickly to a changing market.

Kafrit also says explicitly that its main challenge in the coming year will be to keep operating and deal with uncertainty, and that it will devote integration efforts to Finke. That is an indirect acknowledgment that the next year will not be judged only on sales growth, but on whether the group can absorb a new acquisition without further damaging margins.

What has to happen over the next 2 to 4 quarters

The first requirement is better profitability in North America. A business with NIS 450.8 million of sales and a segment that is barely profitable cannot present a clean story without improvement there. It does not need to snap back to 2024 levels immediately, but it does need to show that current profitability is not the new normal.

The second requirement is for Finke to move from being part of the problem to being part of the solution. If the group continues to add European revenue with negative earnings contribution, the market will increasingly read Kafrit’s acquisition strategy as complexity creation rather than value creation.

The third requirement is for margins to stabilize at a level that justifies the manufacturing footprint. Kafrit is operating at only 63% utilization at the group level and 47% in North America. If demand does not improve, the company will have to prove it can adapt the cost structure rather than simply wait for a better cycle.

The fourth requirement is capital discipline. If parent-level cash stays minimal, the company cannot behave as if 2025 were a peak year. The post-balance-sheet dividend, the option grants and the expansion agenda are all individually understandable, but together they raise the question of whether the pace matches the current operating reality.

Risks

Demand, construction and inventory cycles

The first risk is that the weakness in the second half of 2025 was not just a short cyclical pause. The company itself describes global excess capacity, weak demand in packaging, construction and agriculture, and a slowdown that affected most segments. If customers keep ordering cautiously and continue to keep inventories tight, Kafrit will struggle to improve utilization and margins.

FX and interest rates

This is a real risk, not a technical note. Sales and raw-material purchases are mainly in euros and dollars, and in Asia mostly in yuan, while other expense layers sit in local currencies. The company does hedge part of the exposure through the structure of its borrowings, but it also states clearly that the stronger shekel against the dollar and the yuan hurt revenue and profit in shekel terms. On top of that, 85% of funding sources are floating rate, so higher rates feed directly into the income statement.

Credit quality and collections

The company sells on credit terms of up to 190 to 195 days, and in 2025 it increased its expected-credit-loss allowance to NIS 8.5 million from NIS 6.4 million at the end of 2024. Management already points to a provision of around NIS 4 million for a bankrupt customer in Germany. This is not yet a broad balance-sheet problem, but it is a reminder that even in a diversified customer base, weak conditions in one market can move quickly from revenue to collections.

Financing and covenants

Kafrit is compliant with all financial covenants, but at least one metric is already close to the minimum. The company also relies on available bank facilities and refinancing flexibility. As long as profitability stays reasonable and banks remain open, that works. If 2026 begins with another two or three weak quarters, that cushion could narrow.

Market practicality

Even though this is a real operating company rather than a dream story, the share itself trades with weak daily liquidity. On the latest trading day in the market snapshot, turnover was only about NIS 38 thousand. That does not change the business quality, but it does affect how easily the market can price a story that needs to unfold over several quarters.

Conclusions

Kafrit ends 2025 as a company that still has a wide operating base, diversified customers and positive operating cash flow, but with margins that eroded too quickly and with a new acquisition that has not yet crossed from promise to proof. The central bottleneck is not just end-demand. It is the ability to restore utilization and margins, especially in North America, while integrating Finke and preserving capital discipline. In the near term, the market will focus on one question: was the fourth quarter a trough, or a sign that Kafrit still has not adapted to a harsher industry environment?

Current thesis in one line: Kafrit remains a diversified industrial platform with a coherent strategy, but 2026 will determine whether the recent moves improve earnings quality or simply add complexity.

What changed versus the previous reading: 2025 shifted the center of gravity away from sales growth and portfolio expansion toward earnings quality, parent-level cash access, and whether acquisitions are producing real operating value rather than just more volume.

The strongest counter-thesis: it is possible to argue that the weakness was purely cyclical, that the fourth quarter was distorted by year-end softness and early integration noise, and that 2026 will look much better once Finke stabilizes and the industry backdrop improves.

What could change the market’s interpretation in the short to medium term: a fast recovery in North American profitability, a first clearly positive quarter from Finke, or, on the other side, another quarter of weak margins and overly aggressive capital deployment.

Why this matters: Kafrit is no longer being judged only as a stable plastics-additives manufacturer. It is being judged as a global capital-allocation platform, and the gap between strategic growth and accessible earnings and cash will determine whether that upgrade is real.

What must happen over the next 2 to 4 quarters for the thesis to strengthen: margins need to stabilize, North America needs to return to reasonable profitability, Finke needs to stop dragging results, and the parent layer needs to show that distributions and investments are not coming at the expense of financial flexibility. What would weaken the thesis? Another quarter or two in which revenue broadly holds up but margins keep eroding, or a situation in which strategic growth keeps demanding capital without showing a clear return.